Скачать или смотреть Stop Calling It Microdosing: The Truth About GLP-1 Maintenance Dosing

“Microdosing GLP-1s” is everywhere online—but in clinical practice, the term is often misunderstood. In this video, I break down what GLP-1 microdosing should mean, how it’s used safely, and when it’s appropriate.
I explain why maintenance dosing typically involves decreasing frequency—not reducing the dose itself—and how that preserves metabolic benefits, appetite regulation, and glycemic stability without compromising results. I also outline when smaller titrations are appropriate, who qualifies for maintenance scheduling, and how to avoid common mistakes that lead to plateaus, nausea, or over-restriction.
You’ll learn:
What “GLP-1 microdosing” should mean clinically
Why lowering the frequency (not the dose) is often the correct maintenance strategy
When a reduced dose makes sense—and when it does not
How metabolic stability, hunger cues, and weight-loss durability relate to dosing
How to approach long-term GLP-1 therapy safely and sustainably
This video is ideal for patients wanting clarity and for clinicians trying to combat misinformation about semaglutide, tirzepatide, and long-term GLP-1 management.